DK173716B1 - Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse - Google Patents

Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse Download PDF

Info

Publication number: DK173716B1
Authority: DK; Denmark
Prior art keywords: surfactant; composition according; fluoride; composition; compound
Prior art date: 1986-05-22

Application number

DK198702492A

Other languages

Danish (da)

English (en)

Other versions

DK249287D0 (da

DK249287A (da

Inventor

Pierre Bourbon

Pierre Billot

Pierre Lagny

Original Assignee

Atlantic Pharma Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-22

Filing date

1987-05-14

Publication date

2001-07-23

1986-05-22 Priority claimed from FR8607310A external-priority patent/FR2598916B1/fr

1987-05-14 Application filed by Atlantic Pharma Prod filed Critical Atlantic Pharma Prod

1987-05-14 Publication of DK249287D0 publication Critical patent/DK249287D0/da

1987-11-23 Publication of DK249287A publication Critical patent/DK249287A/da

2001-07-23 Application granted granted Critical

2001-07-23 Publication of DK173716B1 publication Critical patent/DK173716B1/da

Links

239000004094 surface-active agent Substances 0.000 title claims description 22
150000002222 fluorine compounds Chemical class 0.000 title claims description 16
239000008194 pharmaceutical composition Substances 0.000 title claims description 6
239000000203 mixture Substances 0.000 claims abstract description 51
150000001875 compounds Chemical class 0.000 claims abstract description 39
230000002401 inhibitory effect Effects 0.000 claims abstract description 31
241000700605 Viruses Species 0.000 claims abstract description 29
102000004190 Enzymes Human genes 0.000 claims abstract description 19
108090000790 Enzymes Proteins 0.000 claims abstract description 19
239000002537 cosmetic Substances 0.000 claims abstract description 13
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical group [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 30
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 26
229960000686 benzalkonium chloride Drugs 0.000 claims description 25
-1 fluorine ions Chemical class 0.000 claims description 15
229910052731 fluorine Inorganic materials 0.000 claims description 14
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 13
235000013024 sodium fluoride Nutrition 0.000 claims description 13
239000011775 sodium fluoride Substances 0.000 claims description 13
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
239000002280 amphoteric surfactant Substances 0.000 claims description 8
229920001282 polysaccharide Polymers 0.000 claims description 8
239000005017 polysaccharide Substances 0.000 claims description 8
239000011737 fluorine Substances 0.000 claims description 6
239000002736 nonionic surfactant Substances 0.000 claims description 6
NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical class NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 claims description 5
239000003433 contraceptive agent Substances 0.000 claims description 5
230000002254 contraceptive effect Effects 0.000 claims description 5
235000014113 dietary fatty acids Nutrition 0.000 claims description 5
239000000194 fatty acid Substances 0.000 claims description 5
229930195729 fatty acid Natural products 0.000 claims description 5
150000004665 fatty acids Chemical class 0.000 claims description 5
239000003945 anionic surfactant Substances 0.000 claims description 4
239000003093 cationic surfactant Substances 0.000 claims description 4
239000000645 desinfectant Substances 0.000 claims description 4
150000002221 fluorine Chemical class 0.000 claims description 4
229910052751 metal Inorganic materials 0.000 claims description 4
239000002184 metal Substances 0.000 claims description 4
IRPGOXJVTQTAAN-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanal Chemical compound FC(F)(F)C(F)(F)C=O IRPGOXJVTQTAAN-UHFFFAOYSA-N 0.000 claims description 3
XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 3
DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 claims description 3
KLZUFWVZNOTSEM-UHFFFAOYSA-K Aluminum fluoride Inorganic materials F[Al](F)F KLZUFWVZNOTSEM-UHFFFAOYSA-K 0.000 claims description 3
YKGNPIJNTPQMQW-UHFFFAOYSA-N [N+](=O)(O)[O-].C1(=CC=CC=C1)C1[Hg]C=CC=C1 Chemical compound [N+](=O)(O)[O-].C1(=CC=CC=C1)C1[Hg]C=CC=C1 YKGNPIJNTPQMQW-UHFFFAOYSA-N 0.000 claims description 3
239000002253 acid Substances 0.000 claims description 3
239000003904 antiprotozoal agent Substances 0.000 claims description 3
WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims description 3
229910001634 calcium fluoride Inorganic materials 0.000 claims description 3
235000003270 potassium fluoride Nutrition 0.000 claims description 3
239000011698 potassium fluoride Substances 0.000 claims description 3
125000001453 quaternary ammonium group Chemical group 0.000 claims description 3
229960004711 sodium monofluorophosphate Drugs 0.000 claims description 3
YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical group [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims 1
SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 claims 1
239000000126 substance Substances 0.000 abstract description 8
230000006378 damage Effects 0.000 abstract description 6
239000012190 activator Substances 0.000 abstract description 5
230000005764 inhibitory process Effects 0.000 abstract description 5
239000003814 drug Substances 0.000 abstract description 4
238000000034 method Methods 0.000 abstract description 4
238000012360 testing method Methods 0.000 description 34
239000004480 active ingredient Substances 0.000 description 31
230000001150 spermicidal effect Effects 0.000 description 26
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 24
230000000694 effects Effects 0.000 description 21
239000000546 pharmaceutical excipient Substances 0.000 description 19
230000003213 activating effect Effects 0.000 description 18
LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 17
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
239000000243 solution Substances 0.000 description 15
230000002421 anti-septic effect Effects 0.000 description 13
239000003963 antioxidant agent Substances 0.000 description 13
235000006708 antioxidants Nutrition 0.000 description 13
239000008213 purified water Substances 0.000 description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
229940064004 antiseptic throat preparations Drugs 0.000 description 12
150000001450 anions Chemical class 0.000 description 9
239000003795 chemical substances by application Substances 0.000 description 9
239000006071 cream Substances 0.000 description 9
239000000934 spermatocidal agent Substances 0.000 description 9
239000012153 distilled water Substances 0.000 description 8
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 7
239000003381 stabilizer Substances 0.000 description 7
238000004659 sterilization and disinfection Methods 0.000 description 7
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
150000004676 glycans Chemical class 0.000 description 6
150000002500 ions Chemical class 0.000 description 6
229920004918 nonoxynol-9 Polymers 0.000 description 6
229940087419 nonoxynol-9 Drugs 0.000 description 6
239000000829 suppository Substances 0.000 description 6
FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 6
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
230000001066 destructive effect Effects 0.000 description 5
239000003995 emulsifying agent Substances 0.000 description 5
239000000499 gel Substances 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
235000012773 waffles Nutrition 0.000 description 5
241000894006 Bacteria Species 0.000 description 4
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
241000194032 Enterococcus faecalis Species 0.000 description 4
241000588724 Escherichia coli Species 0.000 description 4
YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
241000187480 Mycobacterium smegmatis Species 0.000 description 4
241000589517 Pseudomonas aeruginosa Species 0.000 description 4
241000191967 Staphylococcus aureus Species 0.000 description 4
208000003028 Stuttering Diseases 0.000 description 4
125000002091 cationic group Chemical group 0.000 description 4
229940091249 fluoride supplement Drugs 0.000 description 4
230000006870 function Effects 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
239000000344 soap Substances 0.000 description 4
239000000600 sorbitol Substances 0.000 description 4
239000000758 substrate Substances 0.000 description 4
HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 4
239000000080 wetting agent Substances 0.000 description 4
229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
125000000129 anionic group Chemical group 0.000 description 3
229960001716 benzalkonium Drugs 0.000 description 3
CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 3
229910021538 borax Inorganic materials 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
235000015165 citric acid Nutrition 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
229940079593 drug Drugs 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
239000006260 foam Substances 0.000 description 3
238000005187 foaming Methods 0.000 description 3
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
239000000463 material Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
159000000000 sodium salts Chemical class 0.000 description 3
235000010339 sodium tetraborate Nutrition 0.000 description 3
230000002195 synergetic effect Effects 0.000 description 3
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 3
239000006216 vaginal suppository Substances 0.000 description 3
229940120293 vaginal suppository Drugs 0.000 description 3
RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
CQTZJAKSNDFPOB-UHFFFAOYSA-N 2-naphthyl dihydrogen phosphate Chemical compound C1=CC=CC2=CC(OP(O)(=O)O)=CC=C21 CQTZJAKSNDFPOB-UHFFFAOYSA-N 0.000 description 2
239000005711 Benzoic acid Substances 0.000 description 2
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
229940123208 Biguanide Drugs 0.000 description 2
108090000371 Esterases Proteins 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
239000004166 Lanolin Substances 0.000 description 2
KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
239000000654 additive Substances 0.000 description 2
150000001299 aldehydes Chemical class 0.000 description 2
150000001409 amidines Chemical class 0.000 description 2
230000000843 anti-fungal effect Effects 0.000 description 2
230000000842 anti-protozoal effect Effects 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
229960003237 betaine Drugs 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000000711 cancerogenic effect Effects 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
239000000470 constituent Substances 0.000 description 2
230000036461 convulsion Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000000975 dye Substances 0.000 description 2
229940100242 glycol stearate Drugs 0.000 description 2
229910052736 halogen Inorganic materials 0.000 description 2
150000002367 halogens Chemical class 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000007794 irritation Effects 0.000 description 2
235000019388 lanolin Nutrition 0.000 description 2
229940039717 lanolin Drugs 0.000 description 2
230000007774 longterm Effects 0.000 description 2
239000006210 lotion Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000003921 oil Substances 0.000 description 2
239000007800 oxidant agent Substances 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
239000004014 plasticizer Substances 0.000 description 2
229920000059 polyethylene glycol stearate Polymers 0.000 description 2
229940051841 polyoxyethylene ether Drugs 0.000 description 2
229920000056 polyoxyethylene ether Polymers 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
230000007928 solubilization Effects 0.000 description 2
238000005063 solubilization Methods 0.000 description 2
229940099259 vaseline Drugs 0.000 description 2
238000009736 wetting Methods 0.000 description 2
GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 1
QJRYPNZYBXWKEV-DUQPFJRNSA-N 1-naphthyl N-acetyl-beta-D-glucosaminide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=CC=CC=C12 QJRYPNZYBXWKEV-DUQPFJRNSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical class CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 description 1
ZDSCFBCGDDCJFZ-UHFFFAOYSA-N 2-(methylamino)ethanesulfonic acid;sodium Chemical compound [Na].CNCCS(O)(=O)=O ZDSCFBCGDDCJFZ-UHFFFAOYSA-N 0.000 description 1
MWHKPYATGMFFPI-LJIZCISZSA-N 2-naphthyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(C=CC=C2)C2=C1 MWHKPYATGMFFPI-LJIZCISZSA-N 0.000 description 1
HFJUQSUBZOKELZ-FITDYDNJSA-N 2-naphthyl alpha-L-fucoside Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=CC=C(C=CC=C2)C2=C1 HFJUQSUBZOKELZ-FITDYDNJSA-N 0.000 description 1
KCWQXDQUKLJUEU-UHFFFAOYSA-N 2-naphthyl butyrate Chemical compound C1=CC=CC2=CC(OC(=O)CCC)=CC=C21 KCWQXDQUKLJUEU-UHFFFAOYSA-N 0.000 description 1
CXVZBUOSDMLXNK-UHFFFAOYSA-N 2-naphthyl octanoate Chemical compound C1=CC=CC2=CC(OC(=O)CCCCCCC)=CC=C21 CXVZBUOSDMLXNK-UHFFFAOYSA-N 0.000 description 1
SKRXBZIJSNMVFA-UHFFFAOYSA-N 2-naphthyl tetradecanoate Chemical compound C1=CC=CC2=CC(OC(=O)CCCCCCCCCCCCC)=CC=C21 SKRXBZIJSNMVFA-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
235000019890 Amylum Nutrition 0.000 description 1
101710180684 Beta-hexosaminidase Proteins 0.000 description 1
101710124976 Beta-hexosaminidase A Proteins 0.000 description 1
XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
150000000996 L-ascorbic acids Chemical class 0.000 description 1
JWHURRLUBVMKOT-HNNXBMFYSA-N L-leucine 2-naphthylamide Chemical compound C1=CC=CC2=CC(NC(=O)[C@@H](N)CC(C)C)=CC=C21 JWHURRLUBVMKOT-HNNXBMFYSA-N 0.000 description 1
125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
DEFAKPKFXYITPZ-UHFFFAOYSA-N N-{5-carbamimidamido-1-[(naphthalen-2-yl)amino]-1-oxopentan-2-yl}benzamide Chemical compound C=1C=C2C=CC=CC2=CC=1NC(=O)C(CCCN=C(N)N)NC(=O)C1=CC=CC=C1 DEFAKPKFXYITPZ-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
101710081801 Protein O-GlcNAcase Proteins 0.000 description 1
101710199095 Putative beta-hexosaminidase Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
241000589970 Spirochaetales Species 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000589886 Treponema Species 0.000 description 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
241000045682 Trypauchen vagina Species 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
239000005862 Whey Substances 0.000 description 1
102000007544 Whey Proteins Human genes 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
102000005840 alpha-Galactosidase Human genes 0.000 description 1
108010030291 alpha-Galactosidase Proteins 0.000 description 1
102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
102000019199 alpha-Mannosidase Human genes 0.000 description 1
108010012864 alpha-Mannosidase Proteins 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
150000003868 ammonium compounds Chemical class 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
102000006995 beta-Glucosidase Human genes 0.000 description 1
108010047754 beta-Glucosidase Proteins 0.000 description 1
150000004283 biguanides Chemical class 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
231100000315 carcinogenic Toxicity 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000007865 diluting Methods 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
238000000605 extraction Methods 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
150000002194 fatty esters Chemical class 0.000 description 1
230000035558 fertility Effects 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
235000013350 formula milk Nutrition 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
229920000847 nonoxynol Polymers 0.000 description 1
239000002674 ointment Substances 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
244000052769 pathogen Species 0.000 description 1
150000002960 penicillins Chemical class 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229920000151 polyglycol Polymers 0.000 description 1
239000010695 polyglycol Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
150000004804 polysaccharides Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000012286 potassium permanganate Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
230000010076 replication Effects 0.000 description 1
239000005060 rubber Substances 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
239000002453 shampoo Substances 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
238000004088 simulation Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
KKDONKAYVYTWGY-UHFFFAOYSA-M sodium;2-(methylamino)ethanesulfonate Chemical compound [Na+].CNCCS([O-])(=O)=O KKDONKAYVYTWGY-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000004753 textile Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000004448 titration Methods 0.000 description 1
231100000816 toxic dose Toxicity 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
210000001215 vagina Anatomy 0.000 description 1
150000003751 zinc Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/10—Fluorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Communicable Diseases (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Environmental Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

DK198702492A 1986-05-22 1987-05-14 Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse DK173716B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR8607310A FR2598916B1 (fr)	1986-05-22	1986-05-22	Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide
FR8607310		1986-05-22
EP86402716		1986-12-08
EP86402716A EP0253037B1 (fr)	1986-05-22	1986-12-08	Composition inhibitrice d'au moins un être vivant unicellulaire et/ou virus, procédé de fabrication et applications de cette composition

Publications (3)

Publication Number	Publication Date
DK249287D0 DK249287D0 (da)	1987-05-14
DK249287A DK249287A (da)	1987-11-23
DK173716B1 true DK173716B1 (da)	2001-07-23

Family

ID=26106166

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198702492A DK173716B1 (da)	1986-05-22	1987-05-14	Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse

Country Status (14)

Country	Link
JP (1)	JP2559735B2 (fr)
CN (1)	CN87103752A (fr)
AT (1)	ATE64854T1 (fr)
AU (1)	AU7331287A (fr)
BR (1)	BR8702645A (fr)
CA (1)	CA1326446C (fr)
DK (1)	DK173716B1 (fr)
FI (1)	FI89675C (fr)
HU (1)	HUT43793A (fr)
IE (1)	IE60364B1 (fr)
IL (1)	IL82523A (fr)
NO (1)	NO872142L (fr)
OA (1)	OA08799A (fr)
WO (1)	WO1987007143A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2620620B1 (fr) *	1987-09-22	1991-04-05	Atlantic Pharma Prod	Substance inhibitrice ou destructrice d'au moins un etre vivant unicellulaire renfermant du fluor f- et du lithium li+
ATE78396T1 (de) *	1987-09-23	1992-08-15	Atlantic Pharma Prod	Zusammensetzung zur hemmung oder vernichtung mindestens eines einzelligen lebewesens, enthaltend ein quaternaeres ammoniumfluorid, und verfahren zur herstellung dieses salzes.
GB8809177D0 (en) *	1988-04-19	1988-05-25	Merrell Doe Pharmaceuticals In	Method of preventing aids transmission-resulting from blood transfusions
DE4236090C1 (de) *	1992-10-26	1994-01-05	Asta Medica Arzneimittel	Pharmazeutische Zubereitung für die Fluoridionen-Versorgung
US5658946A (en) *	1996-05-29	1997-08-19	The Procter & Gamble Company	Methods for the treatment of herpes virus infections
RU2259825C9 (ru)	2001-06-18	2006-04-10	БиоДием Лимитед	Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
JP4759104B2 (ja) *	2005-08-26	2011-08-31	株式会社ユネクス	センサ保持装置
JP6204729B2 (ja) *	2013-07-10	2017-09-27	花王株式会社	水溶性ポリマー組成物
WO2015161860A1 (fr) *	2014-04-25	2015-10-29	Frank Flechsig	Compositions biocides améliorées à base de fluorure de calcium, et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH448388A (de) *	1963-12-30	1967-12-15	Ciba Geigy	Neues Zahnpflegemittel
US3647700A (en) *	1967-08-14	1972-03-07	Commodity Improvements Inc	K2zrf6
US3996350A (en) *	1975-01-02	1976-12-07	Geraldine Fay Weisz	Methods and compositions for alleviating fungus infections of the skin
US3995029A (en) *	1975-01-02	1976-11-30	Geraldine Fay Weisz	Methods for the treatment of acne
US4097590A (en) *	1975-07-24	1978-06-27	Geraldine Fay Weisz	Methods and compositions for treatment of bacterial and fungus infections of the skin
SE444112B (sv) *	1978-06-15	1986-03-24	Dental Therapeutics Ab	Rengoringsmedel for dentinytor
US4368186A (en) *	1981-05-07	1983-01-11	Syntex (U.S.A.) Inc.	Methods and compositions for intravaginal contraception
US4359475A (en) *	1981-12-21	1982-11-16	Syntex (U.S.A.) Inc.	Thioketal substituted N-alkyl imidazoles
US4473547A (en) *	1982-11-18	1984-09-25	Johnson & Johnson Products Inc.	Anticaries compositions

1986
- 1986-12-08 AT AT86402716T patent/ATE64854T1/de not_active IP Right Cessation
1987
- 1987-05-14 DK DK198702492A patent/DK173716B1/da not_active IP Right Cessation
- 1987-05-14 IL IL82523A patent/IL82523A/xx not_active IP Right Cessation
- 1987-05-21 IE IE133887A patent/IE60364B1/en not_active IP Right Cessation
- 1987-05-21 JP JP62122683A patent/JP2559735B2/ja not_active Expired - Lifetime
- 1987-05-21 FI FI872253A patent/FI89675C/fi not_active IP Right Cessation
- 1987-05-21 HU HU872284A patent/HUT43793A/hu unknown
- 1987-05-21 CA CA000537680A patent/CA1326446C/fr not_active Expired - Fee Related
- 1987-05-21 NO NO872142A patent/NO872142L/no unknown
- 1987-05-22 AU AU73312/87A patent/AU7331287A/en not_active Abandoned
- 1987-05-22 CN CN198787103752A patent/CN87103752A/zh active Pending
- 1987-05-22 BR BR8702645A patent/BR8702645A/pt unknown
- 1987-05-22 WO PCT/FR1987/000181 patent/WO1987007143A1/fr not_active Ceased
1988
- 1988-01-22 OA OA59266A patent/OA08799A/fr unknown

Also Published As

Publication number	Publication date
ATE64854T1 (de)	1991-07-15
OA08799A (fr)	1989-03-31
IL82523A (en)	1992-05-25
AU7331287A (en)	1987-11-26
JP2559735B2 (ja)	1996-12-04
IE871338L (en)	1987-11-22
HUT43793A (en)	1987-12-28
CA1326446C (fr)	1994-01-25
NO872142D0 (no)	1987-05-21
CN87103752A (zh)	1988-09-21
FI872253A0 (fi)	1987-05-21
NO872142L (no)	1987-11-23
IL82523A0 (en)	1987-11-30
IE60364B1 (en)	1994-07-13
FI872253A7 (fi)	1987-11-23
FI89675C (fi)	1993-11-10
FI89675B (fi)	1993-07-30
JPS6322023A (ja)	1988-01-29
BR8702645A (pt)	1988-02-23
DK249287D0 (da)	1987-05-14
DK249287A (da)	1987-11-23
WO1987007143A1 (fr)	1987-12-03

Legal Events

Date	Code	Title	Description
2001-07-23	B1	Patent granted (law 1993)
2007-01-15	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
US6355684B1 (en)	2002-03-12	Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6709681B2 (en)	2004-03-23	Acidified nitrite as an antimicrobial agent
US8901172B2 (en)	2014-12-02	Method for treating an inflammation or lesion caused by a virus
US3751562A (en)	1973-08-07	Medicated gelled oils
CN102317429A (zh)	2012-01-11	抗微生物可发泡皂
Chhetri et al.	2010	Formulation and evaluation of antimicrobial herbal ointment
CA2439413C (fr)	2017-01-03	Compositions virucides
US5026561A (en)	1991-06-25	Method which inhibits or destroys at least one unicellular living organism containing a quaternary ammonium fluoride
EP0457805A1 (fr)	1991-11-27	Desinfectant biodegradable
US4917901A (en)	1990-04-17	Methods and compositions for inhibiting or destroying spermatozoa and organisms which causes sexually transmitted diseases in mammalian host
US5458889A (en)	1995-10-17	Methods and compositions for inhibiting or destroying viruses or retroviruses
FI89675C (fi)	1993-11-10	Icke-farmaceutisk komposition som innehaoller en ytaktiv foerening och en fluorfoerening
JP2777148B2 (ja)	1998-07-16	少なくとも１種の単細胞生物を阻害し，又は破壊する，弗素Ｆ▲上−▼及びリチウムＬｉ▲上＋▼を含む組成物
RU2158143C1 (ru)	2000-10-27	Антисептическая жидкость "велталекс-м"
RU2175247C1 (ru)	2001-10-27	Антисептическая композиция и способ ее приготовления
JPH01163119A (ja)	1989-06-27	第四アンモニウムフルオリドを含む，少なくとも一種の単細胞生物を抑制または駆除する組成物，及びその塩の製造方法
CA2398399A1 (fr)	2001-08-02	Procedes et dispositifs pour prevenir la transmission de maladies sexuellement transmissibles
Brampton	2018	PRTARO-BENZOYL PEROXIDE/CLINDAMYCIN KIT TOPICAL GEL
HK1164359A (en)	2012-09-21	Antimicrobial foamable soaps
HK1055897A1 (en)	2004-01-30	Antimicrobial compositions and methods of use
HK1055897B (en)	2012-08-31	Antimicrobial compositions and methods of use
BR102015003322A2 (pt)	2017-07-11	Pharmaceutical composition containing aminoguanidine derivatives with anti-psytic activity